Premium
Parathyroid Adenoma Localization: Surgeon‐Performed Ultrasound Versus Sestamibi
Author(s) -
Steward David L.,
Danielson Gregory P.,
Afman Chad E.,
Welge Jeffrey A.
Publication year - 2006
Publication title -
the laryngoscope
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.181
H-Index - 148
eISSN - 1531-4995
pISSN - 0023-852X
DOI - 10.1097/01.mlg.0000227957.06529.22
Subject(s) - medicine , quadrant (abdomen) , ultrasound , parathyroidectomy , parathyroid adenoma , primary hyperparathyroidism , radiology , adenoma , cohort , nuclear medicine , surgery , parathyroid hormone , calcium
Objectives: Compare surgeon‐performed ultrasound versus sestamibi for preoperative parathyroid adenoma localization. Study Design: Single‐institutional cohort. Methods: One hundred six consecutive patients undergoing parathyroidectomy at an academic institution between 2004 to 2005 were included. Of those, 103 underwent both surgeon‐performed ultrasound and sestamibi‐Tc99m localization preoperatively. Primary outcome is sensitivity for adenoma localization to correct quadrant (right vs. left, superior vs. inferior). Results: Hypercalcemia resolved in 97% of patients. Sensitivities for correct quadrant localization for ultrasound versus sestamibi were 87% versus 58% ( P < .001). Specificities were 95%. Positive and negative predictive values were 85% versus 78% and 96% versus 87%, respectively. Combined sensitivity was 93%. Sensitivities for correct side localization were 91% and 74% ( P = .002). Conclusions: Ultrasound appears more sensitive than sestamibi for localization to correct quadrant or side when performed in‐office by the author in this cohort.